GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

NCT00110721 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Study protocol amended to a new treatment regimen: study DAVFU-006.

Conditions

Colorectal Cancer

Interventions

DRUG: GM-CT-01 plus 5-Fluorouracil

Sponsor

Galectin Therapeutics Inc.